Skip to main content
Blood test

Lucence CardioHemeRISK

See whether acquired blood-cell mutations add context to your heart attack, stroke, and leukemia risk.

$642.60 Member price Member price with the $9/month membership. Plus a one-time lab draw fee, passed through at cost. $899.64 Non-member
Excellent 4.8 out of 5
  • No doctor visit or referral needed
  • Members pay our cost on every test, never a markup
  • Tracked over time alongside your other results
  • HSA/FSA eligible
  • Typical results in about 12 working days · Reviewed by a real clinician
  • Drawn at a CLIA/CAP-accredited lab near you · Find labs

Why people order the Lucence CardioHemeRISK

  • Risk context beyond cholesterol

    This test examines acquired blood-cell mutations, which answer a different question from lipid markers, blood pressure, or inherited-risk testing.

Who may consider the Lucence CardioHemeRISK

  • Age-related risk context

    Clonal hematopoiesis becomes more common with age. Age 40 and above is a recommendation, not a requirement, and being under 40 is not automatically disqualifying.

  • Personal or family history

    A history of early cardiovascular events or blood cancer may make an additional risk-assessment conversation useful, but this test does not diagnose either condition.

  • Clinician-guided risk assessment

    A clinician can interpret a detected clone alongside standard cardiovascular and hematology evaluation and decide whether follow-up is appropriate.

Is this the right test if I want a standard cardiovascular risk assessment?

No. Choose standard cardiovascular evaluation first, including blood pressure and lipid assessment. CardioHemeRISK may add a different layer of acquired-mutation context, but it does not replace those tests.

Should I choose this instead of inherited heart or cancer genetic testing?

No. CardioHemeRISK looks for acquired mutations in blood-forming cells, not variants you were born with. Choose germline testing only through an appropriate inherited-risk pathway.

Can I consider this test if I am under 40?

Yes, being under 40 is not automatically disqualifying. Age 40 and above is a recommendation, so discuss your history and goals with a clinician before deciding.

Is this appropriate if I have symptoms or a suspected blood disorder?

Do not use this screen to evaluate urgent symptoms or replace a diagnostic workup. Seek clinician-directed testing, especially for chest pain, stroke symptoms, unexplained blood-count changes, or other concerning findings.

Where is this test available?

This test is not available in Pennsylvania, New York, or Rhode Island.

How should I prepare for the blood draw?

Fasting is not required. Avoid a heavy meal before your draw. Have your blood drawn in the comfort of your home at no additional cost. Tell your care team about recent surgery, blood transfusion, or bone marrow transplant so they can confirm timing and eligibility.

What members say on Trustpilot

  • “Mito gives me 3x the tests for less money” · Page
  • “15/10 experience - I felt actually taken care of” · Reena Sudan
  • “Deeper insights than a typical annual physical” · Nicki H
  • “Loved how specific and actionable the advice was” · Maya Hickey
  • “Stunned at how thorough both the testing and analysis was” · Mark
  • “Tired of arguing with my PCP. Mito got me the answers I was looking for.” · Josh
  • “So easy, it feels like a deluxe experience for your health” · Menetreto
  • “Excellent responsive customer service (a real rarity these days!)” · SS

What the Lucence CardioHemeRISK measures

CardioHemeRISK is a blood-based next-generation sequencing risk assessment for clonal hematopoiesis, the expansion of blood-forming cell clones that carry acquired mutations. It examines ASXL1, CALR, DNMT3A, FLT3, IDH1, IDH2, JAK2, MPL, PPM1D, RUNX1, SF3B1, SRSF2, TET2, TP53, and U2AF1. The shared clonal signal is used to add context to heart attack, stroke, and leukemia risk.

These mutations are acquired during life, not inherited germline variants. The test is also different from cholesterol, lipoprotein, blood-pressure, imaging, and blood-count testing. It is a risk-assessment aid, not a diagnosis or a prediction that an event will occur, and it does not replace standard cardiovascular or hematology assessment.

Specimen
Blood sample
Biomarker count
0 biomarkers
Fasting
Not required
Results
On your Mito dashboard in about 12 working days, with your range explained

Your results

How to understand your Lucence CardioHemeRISK result

Interpret the report with a clinician. Age, blood counts, cardiovascular risk factors, medical history, and the performing laboratory's reporting criteria all matter.

No clonal signal detected

No reportable mutation is found across the 15-gene scope. This lowers concern from this assay but does not eliminate cardiovascular or blood-cancer risk.

Clonal signal detected

One or more acquired mutations are reported with the laboratory's available clone context. A detected clone is not a diagnosis. Its meaning depends on the gene, clone features, blood counts, history, and standard risk assessment.

How much the Lucence CardioHemeRISK costs

Compare exact Mito member and non-member prices with recently checked comparable offers. Collection and lab fees are shown separately.

Lab Test price Collection or lab fee
Mito member $642.60 $0.00 Added once per order
Mito non-member $899.64 $0.00 Added once per order

Mito prices come from the live catalog for the selected provider.

How it works

What to expect from your Lucence CardioHemeRISK

  1. 1 Book instantly

    Click, book, done. Choose a convenient lab location near you. Transparent, up-front pricing.

  2. 2 Quick lab visit

    Testing to fit your schedule, usually 15 minutes or less. Walk-in and appointments available. No fasting needed.

  3. 3 Results in about 12 working days

    Your result posts straight to your dashboard as soon as the lab completes it.

  4. 4 Expert guidance

    With membership, a clinician reviews your result and a personalized action plan follows, with clear next steps.

Mito dashboard showing biological age, health categories, biomarkers, and health trends

Every result comes with a plan

A number on its own does not tell you much. Membership is what turns it into next steps, and keeps track of what changes.

  • Insights that connect the dots. A clinician reads your whole picture, not one result in isolation, connecting family history, past results, and lifestyle into clear next steps.

  • Your personalized action plan. Nutrition, supplements, and training in one clinician-reviewed protocol, updated as your results change.

  • Track your trends. Upload results from any lab and see each biomarker trend over time, so you know what is working.

  • Never miss a recheck. Mito tells you what is worth retesting and when, then reminds you so nothing slips.

Accredited and reviewed

Lucence CardioHemeRISK testing you can trust

Run to clinical-grade standards

CLIA certified
CAP accredited
HIPAA compliant
  • Processed at the same CLIA and CAP-accredited national labs your doctor uses
  • Order online, no doctor visit or referral needed
  • Your data is encrypted, handled under HIPAA, and never sold
Rhonda Collins, FNP-C, Mito Care Team Lead
Clinician-reviewed

Overseen by our Care Team Lead

Every result, including your Mito Brain analysis, is checked by Rhonda Collins, FNP-C, our Care Team Lead and a board-certified Family Nurse Practitioner with over 15 years of nursing experience across cardiac ICU, primary care, and dermatology.

Meet Rhonda

What members are saying

Excellent 4.8 out of 5
  • @nasdaily

  • 15/10 experience - I felt actually taken care of

    Super impressed with my Mito experience - the thoroughness of the intake, the data tracking and the doctor's visit.

    RS Reena Sudan
  • @ellarosemcfadin

  • Helped show an overall picture

    I would highly recommend this service to anyone that wants a more in-depth picture of their health and labs. The platform is super user friendly.

    BS Bo Sal
  • @katelyn_kim

  • Specific and actionable advice

    It felt like, for the first time, I had real data guiding me to make meaningful changes and I've definitely noticed the difference.

    MH Maya Hickey
  • @bryce_witmer

  • Tired of arguing with my PCP

    After extensive research, I decided Mito was the best option. The insights were clear and make sense. Mito gave me peace of mind and a path to follow.

    JO Josh
  • @alexandradawson

  • 3x the tests for less money

    A great alternative to the basic blood work at your local clinic. Love the report card format. Much better value.

    P Page
  • @daniklass

  • Best $9 a month I spend

    The action plan changes every time new results come in. I've actually never had a health company recommend doing less. Refreshing.

    DP Devi Patel
  • @natalieefer

  • Finally, prices that make sense

    Every test is published. I can see what it costs and what I save as a member. No surprises.

    KT Kenji Tanaka
  • @tyler_sarkisian

Everything your health needs,
in one membership

  • A Mito member relaxing at home, checking their results on their phone

    Every test at our cost

    Members pay our cost on every test, with lab fees passed straight through. The full receipt is itemized, never padded.

  • Mito dashboard on a tablet showing biomarker results and trends

    Continuous tracking, all in one place

    Upload past labs and watch your trends over time. Every marker and visit lives in one longitudinal record, so all your care stays together.

  • A Mito clinician checking in with a member over text messaging

    Year-round clinician support

    Text anytime and get clinician-reviewed answers. When you want to go deeper, 1:1 consultations are available at affordable rates.

Common Lucence CardioHemeRISK questions

What is clonal hematopoiesis?
It is the growth of a group of blood-forming cells that share an acquired mutation. It becomes more common with age and can be associated with cardiovascular and blood-cancer risk.
Why are heart attack, stroke, and leukemia considered together?
All three outputs draw on the same underlying clonal hematopoiesis signal, although each outcome has different biology and follow-up.
Does a detected mutation mean I have leukemia?
No. A detected clone is not a leukemia diagnosis. A clinician may review blood counts, clone characteristics, symptoms, and whether hematology follow-up is appropriate.
Does no clonal signal mean my cardiovascular risk is low?
No. It only means this assay did not find a reportable clonal signal. Standard risk factors such as blood pressure, cholesterol, diabetes, smoking, and family history still matter.
Is this an inherited genetic test?
No. It looks for mutations acquired in blood-forming cells during life and does not assess inherited germline risk.
Is this the same as a cholesterol test?
No. It does not measure cholesterol, Apo B, Lp(a), or particle size. Those tests remain important for standard cardiovascular assessment.
Can the test predict when a heart attack, stroke, or leukemia will occur?
No. It provides risk context, not a timeline or certainty that an event will happen.
What follow-up can a detected clonal signal lead to?
A clinician may review the gene finding, blood counts, cardiovascular risk factors, and history, then decide whether repeat testing or specialist evaluation is warranted.
Does this replace a complete blood count or cardiovascular workup?
No. It complements rather than replaces standard laboratory testing, examination, imaging, or specialist care.

Your privacy choices

We use cookies to run our site, understand usage, and support marketing. You can anytime.

Your cart

Checkout

Complete your order

Send this cart as a gift

Each checkout sends one gift to one recipient. To gift another person, complete a separate checkout.

Email delivery

Set your location

Select your state to see the tests and labs available near you.

Mito Concierge

Hello

I can build you a panel, explain what your biomarkers mean, and find the cheapest lab near you.

Loading sign in…